SEC CIK 1122124
ELSON CHARLES M
Reported ownership across 2 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| EHCview stock → | 82,981 | 2022-04-18 |
| AZOview stock → | 5,622 | 2008-11-03 |
Position History — AZO
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — AZO
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2008-12-01 | Grant / award (derivative) | 19.5 | $108.92 | 3,262.7 |
| 2008-11-03 | Open-market sale | 402 | $122.19 | 5,622 |
| 2008-11-03 | Open-market sale | 5,622 | $122.48 | 0 |
| 2008-10-31 | Open-market sale | 600 | $128.41 | 10,024 |
| 2008-10-31 | Open-market sale | 500 | $127.54 | 13,224 |
| 2008-10-31 | Open-market sale | 500 | $128.12 | 12,724 |
| 2008-10-31 | Open-market sale | 500 | $128.16 | 12,224 |
| 2008-10-31 | Open-market sale | 500 | $127.29 | 11,724 |
| 2008-10-31 | Open-market sale | 500 | $127.75 | 11,224 |
| 2008-10-31 | Open-market sale | 600 | $127.72 | 10,624 |
| 2008-10-31 | Open-market sale | 500 | $128.10 | 13,724 |
| 2008-10-31 | Open-market sale | 700 | $127.61 | 9,324 |
| 2008-10-31 | Open-market sale | 700 | $127.73 | 8,624 |
| 2008-10-31 | Open-market sale | 800 | $128.13 | 7,824 |
| 2008-10-31 | Open-market sale | 800 | $127.56 | 7,024 |
| 2008-10-31 | Open-market sale | 1,000 | $128.00 | 6,024 |
| 2008-10-31 | Open-market sale | 400 | $128.29 | 14,224 |
| 2008-10-31 | Open-market sale | 300 | $128.23 | 19,224 |
| 2008-10-31 | Open-market sale | 200 | $128.30 | 20,724 |
| 2008-10-31 | Open-market sale | 200 | $127.88 | 20,524 |
| 2008-10-31 | Open-market sale | 200 | $128.28 | 20,324 |
| 2008-10-31 | Open-market sale | 200 | $127.32 | 20,124 |
| 2008-10-31 | Open-market sale | 200 | $128.03 | 19,924 |
| 2008-10-31 | Open-market sale | 200 | $128.32 | 19,724 |
| 2008-10-31 | Open-market sale | 200 | $127.30 | 19,524 |
| 2008-10-31 | Open-market sale | 200 | $128.34 | 20,924 |
| 2008-10-31 | Open-market sale | 300 | $128.04 | 18,924 |
| 2008-10-31 | Open-market sale | 300 | $128.22 | 18,624 |
| 2008-10-31 | Open-market sale | 300 | $127.67 | 18,324 |
| 2008-10-31 | Open-market sale | 300 | $127.16 | 18,024 |
| 2008-10-31 | Open-market sale | 300 | $127.28 | 17,724 |
| 2008-10-31 | Open-market sale | 300 | $128.08 | 17,424 |
| 2008-10-31 | Open-market sale | 200 | $128.05 | 21,124 |
| 2008-10-31 | Open-market sale | 200 | $127.51 | 21,324 |
| 2008-10-31 | Open-market sale | 200 | $127.87 | 21,524 |
| 2008-10-31 | Open-market sale | 200 | $127.60 | 21,724 |
| 2008-10-31 | Open-market sale | 108 | $127.11 | 21,924 |
| 2008-10-31 | Open-market sale | 100 | $127.66 | 22,032 |
| 2008-10-31 | Open-market sale | 100 | $127.49 | 22,132 |
| 2008-10-31 | Open-market sale | 400 | $127.52 | 14,624 |
| 2008-10-31 | Open-market sale | 400 | $128.01 | 15,024 |
| 2008-10-31 | Open-market sale | 400 | $128.33 | 15,424 |
| 2008-10-31 | Open-market sale | 400 | $127.12 | 15,824 |
| 2008-10-31 | Open-market sale | 300 | $128.09 | 16,224 |
| 2008-10-31 | Open-market sale | 300 | $128.14 | 16,524 |
| 2008-10-31 | Open-market sale | 300 | $127.68 | 16,824 |
| 2008-10-31 | Open-market sale | 300 | $128.27 | 17,124 |
| 2008-10-31 | Option exercise (derivative) | 3,608 | $23.06 | 0 |
| 2008-10-31 | Open-market sale | 100 | $127.50 | 23,532 |
| 2008-10-31 | Open-market sale | 100 | $127.69 | 23,632 |
| 2008-10-31 | Open-market sale | 100 | $127.63 | 23,732 |
| 2008-10-31 | Open-market sale | 100 | $128.07 | 23,832 |
| 2008-10-31 | Open-market sale | 100 | $127.95 | 23,932 |
| 2008-10-31 | Open-market sale | 100 | $127.96 | 24,032 |
| 2008-10-31 | Open-market sale | 100 | $127.71 | 24,132 |
| 2008-10-31 | Open-market sale | 100 | $128.18 | 24,232 |
| 2008-10-31 | Open-market sale | 100 | $127.17 | 24,332 |
| 2008-10-31 | Open-market sale | 100 | $127.53 | 24,432 |
| 2008-10-31 | Open-market sale | 100 | $127.27 | 24,532 |
| 2008-10-31 | Option exercise | 3,000 | $72.53 | 24,632 |
| 2008-10-31 | Option exercise | 3,000 | $71.18 | 21,632 |
| 2008-10-31 | Option exercise | 3,000 | $90.46 | 18,632 |
| 2008-10-31 | Option exercise | 3,000 | $28.03 | 15,632 |
| 2008-10-31 | Option exercise | 3,000 | $85.10 | 12,632 |
| 2008-10-31 | Option exercise | 3,608 | $23.06 | 9,632 |
| 2008-10-31 | Open-market sale | 100 | $128.26 | 22,232 |
| 2008-10-31 | Open-market sale | 100 | $128.53 | 22,332 |
| 2008-10-31 | Open-market sale | 100 | $128.19 | 22,432 |
| 2008-10-31 | Open-market sale | 100 | $127.94 | 22,532 |
| 2008-10-31 | Open-market sale | 100 | $127.74 | 22,632 |
| 2008-10-31 | Open-market sale | 100 | $127.89 | 22,732 |
| 2008-10-31 | Open-market sale | 100 | $128.06 | 22,832 |
| 2008-10-31 | Open-market sale | 100 | $127.62 | 22,932 |
| 2008-10-31 | Open-market sale | 100 | $127.31 | 23,032 |
| 2008-10-31 | Open-market sale | 100 | $128.11 | 23,132 |
| 2008-10-31 | Open-market sale | 100 | $127.58 | 23,232 |
| 2008-10-31 | Open-market sale | 100 | $128.58 | 23,332 |
| 2008-10-31 | Open-market sale | 100 | $127.57 | 23,432 |
| 2008-09-01 | Grant / award (derivative) | 81.3 | $138.34 | 3,243.2 |
| 2008-06-01 | Grant / award (derivative) | 88.6 | $126.95 | 3,161.9 |
| 2008-03-01 | Grant / award (derivative) | 96.1 | $117.02 | 3,073.3 |
| 2008-01-01 | Grant / award (derivative) | 3,000 | $0.00 | 3,000 |
| 2007-12-01 | Grant / award (derivative) | 100.4 | $112.04 | 2,977.2 |
| 2007-09-01 | Grant / award (derivative) | 92.9 | $121.10 | 2,876.8 |
| 2007-06-01 | Grant / award (derivative) | 87.6 | $128.47 | 2,783.9 |
| 2007-03-01 | Grant / award (derivative) | 89.9 | $125.17 | 2,696.3 |
| 2007-01-01 | Grant / award (derivative) | 3,000 | $0.00 | 3,000 |
| 2006-12-01 | Grant / award (derivative) | 99.3 | $113.29 | 2,606.4 |
| 2006-09-01 | Grant / award (derivative) | 124.6 | $90.30 | 2,507.1 |
| 2006-06-01 | Grant / award (derivative) | 125.2 | $89.87 | 2,382.5 |
| 2006-03-01 | Grant / award (derivative) | 115.1 | $97.71 | 2,257.3 |
| 2006-01-01 | Grant / award (derivative) | 3,000 | $0.00 | 3,000 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.